First Trust Direct Indexing’s Amphastar Pharmaceuticals AMPH Stock Holding History

First Trust Direct Indexing’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,527	Closed	-$260K	–	700
2023 Q2	$260K	Sell	4,527 -4,338	-49%	-$192K	0.03%	585
2023 Q1	$332K	Sell	8,865 -395	-4%	-$12.9K	0.04%	510
2022 Q4	$259K	Sell	9,260 -618	-6%	-$17.9K	0.03%	550
2022 Q3	$278K	Buy	9,878 +32	+0.3%	+$1.04K	0.04%	488
2022 Q2	$343K	Buy	9,846 +311	+3%	+$11.1K	0.05%	433
2022 Q1	$342K	Sell	9,535 -30	-0.3%	-$851	0.04%	463
2021 Q4	$223K	Buy	+9,565	New	+$196K	0.03%	578
2021 Q3	–	Sell	-11,949	Closed	-$241K	–	652
2021 Q2	$241K	Buy	11,949 +36	+0.3%	+$678	0.04%	516
2021 Q1	$218K	Buy	11,913 +321	+3%	+$5.97K	0.06%	357
2020 Q4	$233K	Buy	+11,592	New	+$226K	0.06%	334

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First Trust Direct Indexing's AMPH Position: Q3 2023 in Review

First Trust Direct Indexing sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2023, closing a stake of 4,527 shares — an estimated $260K sold.

First Trust Direct Indexing first reported a position in AMPH in Q4 2020 and held it in 10 quarters. The position peaked at $343K in Q2 2022. 255 funds tracked by Wall St. Rank hold AMPH as of Q3 2023.

First Trust Direct Indexing reported no remaining Amphastar Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
First Trust Direct Indexing sold 4,527 Amphastar Pharmaceuticals shares in Q3 2023, an estimated $260K.
First Trust Direct Indexing first reported a position in Amphastar Pharmaceuticals in Q4 2020 and held it in 10 quarters.
First Trust Direct Indexing's Amphastar Pharmaceuticals position peaked at $343K in Q2 2022.
255 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2023.

Based on First Trust Direct Indexing's 13F filing for Q3 2023, filed 30 Oct 2023.